A method of chromatography using semi-synthetic heparin ligands

Details for Australian Patent Application No. 2006316039 (hide)

Owner GE Healthcare Bio-Sciences AB

Inventors Alterman, Mathias; Thevenin, Nicolas

Agent Davies Collison Cave

Pub. Number AU-B-2006316039

PCT Pub. Number WO2007/058592

Priority 0502569-7 21.11.05 SE

Filing date 15 November 2006

Wipo publication date 24 May 2007

Acceptance publication date 18 August 2011

International Classifications

B01D 15/20 (2006.01) Separating processes involving the treatment of liquids with solid sorbents

B01J 20/26 (2006.01) Solid sorbent compositions

C07K 1/22 (2006.01) General processes for the preparation of peptides

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C08B 37/10 (2006.01) Preparation of polysaccharides not provided for in

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 9/74 (2006.01) Enzymes, e.g. ligases (6.) - Thrombin

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/058592 Priority application(s): WO2007/058592

18 August 2011 Application Accepted

  Published as AU-B-2006316039

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316049-Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, Alzheimer's Disease, neurodegeneration and dementia.

2006316036-A compound comprising an autoantigenic peptide and a carrier with a MHC binding motif